tiprankstipranks
Trending News
More News >
Globe Life (GL)
NYSE:GL
Advertisement

Globe Life (GL) AI Stock Analysis

Compare
624 Followers

Top Page

GL

Globe Life

(NYSE:GL)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 4o)
Rating:71Outperform
Price Target:
$148.00
▲(11.92% Upside)
Globe Life's overall stock score reflects strong financial performance and positive earnings call highlights, including robust revenue growth and profitability. The attractive valuation further supports the score. However, technical indicators suggest short-term weakness, and challenges in specific segments were noted in the earnings call.
Positive Factors
Revenue Growth
Consistent revenue growth in both life and health insurance segments indicates strong market demand and effective sales strategies, supporting long-term business expansion.
Exclusive Agency Force
A growing exclusive agency force enhances distribution capabilities and customer reach, providing a competitive edge in acquiring new policyholders and sustaining revenue growth.
Investment Portfolio Performance
Strong investment performance contributes to financial stability and profitability, allowing the company to effectively manage liabilities and support future growth initiatives.
Negative Factors
Decline in Direct-to-Consumer Life Premiums
A decline in direct-to-consumer premiums suggests challenges in this distribution channel, potentially impacting market share and revenue diversification efforts.
Negative Free Cash Flow Growth
Negative free cash flow growth could signal potential cash flow challenges, affecting the company's ability to invest in growth opportunities and manage debt efficiently.
Gross Profit Margin Decline
A declining gross profit margin may indicate rising costs or pricing pressures, which could impact profitability and necessitate improved cost management strategies.

Globe Life (GL) vs. SPDR S&P 500 ETF (SPY)

Globe Life Business Overview & Revenue Model

Company DescriptionGlobe Life Inc. is a leading provider of life and supplemental health insurance in the United States. Founded in 1951 and headquartered in McKinney, Texas, the company operates primarily in the life insurance sector, offering a range of products that include term life, whole life, and accidental death insurance. Additionally, Globe Life provides various supplemental health insurance products, such as cancer, critical illness, and accident insurance, targeting individuals and families seeking financial protection against unforeseen circumstances.
How the Company Makes MoneyGlobe Life generates revenue primarily through the sale of insurance premiums. The company earns money by underwriting life and health insurance policies, collecting premiums from policyholders, and investing those premiums in various financial instruments, such as bonds and stocks, to yield investment income. The core revenue streams include individual life insurance products, which provide long-term financial protection, and supplemental health insurance products that cover specific health-related expenses. Furthermore, Globe Life benefits from a network of independent agents and marketing partnerships that help distribute its products, enhancing its reach and customer acquisition efforts. Additionally, the company may generate income from policy renewals and persistency, where customers continue to pay premiums for their policies over time.

Globe Life Key Performance Indicators (KPIs)

Any
Any
Insurance Premium Revenue by Segment
Insurance Premium Revenue by Segment
Shows the distribution of premium income across different insurance segments, highlighting which areas drive the most revenue and indicating potential growth or risk in specific markets.
Chart InsightsGlobe Life's life insurance segment shows steady growth, with premium revenue up 3% to $840 million, driven by a 6% increase in underwriting margins. The health segment also experienced an 8% rise in premium revenue to $378 million, although its underwriting margin declined by 2%. The company's strategic focus on expanding its agent count by 6% and enhancing direct-to-consumer sales is expected to support sustainable growth. However, challenges like declining net investment income and unrealized losses in the investment portfolio could impact future profitability.
Data provided by:Main Street Data

Globe Life Earnings Call Summary

Earnings Call Date:Oct 29, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:May 06, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted strong growth in net income, insurance operations, and agent recruiting, as well as positive investment yields and favorable mortality experience. However, there were challenges with flat sales in some segments, a decline in direct-to-consumer life premiums, low growth in net investment income, and a decrease in excess investment income.
Q3-2025 Updates
Positive Updates
Strong Earnings and Growth in Net Income
Net income for the third quarter was $388 million or $4.73 per share, compared to $303 million or $3.44 per share a year ago. Net operating income increased by 38% year-over-year.
Solid Growth in Insurance Operations
Total premium revenue grew 5% over the year-ago quarter. Life premium revenue increased by 3% to $844 million, and health insurance premium revenue grew 9% to $387 million.
Exclusive Agency Force and Recruiting Momentum
The company has over 17,500 exclusive agents, with an agent count nearly doubling over the past 10 years. American Income hires were up 17% and Liberty National hires were up 15% from a year ago.
Positive Investment Portfolio Performance
Invested $279 million in fixed maturities with an average yield of 6.33% and $86 million in commercial mortgage loans with an expected cash return of 9%.
Favorable Mortality Experience
Life underwriting margin increased by 24% due to premium growth and favorable mortality experience.
Negative Updates
Flat Sales in Some Segments
Net life sales at American Income were flat compared to a year ago, and Liberty National's net life sales were also flat.
Decline in Direct-to-Consumer Life Premiums
Life premiums in the direct-to-consumer channel were down 1% year-over-year, despite a 13% increase in net life sales.
Low Growth in Net Investment Income
Net investment income was slightly above last year's third quarter, with low growth in average invested assets.
Excess Investment Income Decline
Excess investment income was $37 million, down approximately $3 million from the year-ago quarter.
Company Guidance
In the Globe Life Inc. third-quarter earnings call for fiscal year 2025, the company reported significant growth in key financial metrics. Net income was $388 million, or $4.73 per share, compared to $303 million, or $3.44 per share, in the same quarter of the previous year. Net operating income increased to $394 million, or $4.81 per share, reflecting a 38% rise from $3.49 per share a year ago. The return on equity (ROE) through September 30 on a GAAP basis was 21.9%, with a book value per share of $69.52. Excluding Accumulated Other Comprehensive Income (AOCI), ROE was 16.6%, and book value per share was $93.63, marking a 12% increase from last year. Total premium revenue for the quarter grew by 5%, with life premium revenue rising 3% to $844 million and health insurance premium revenue jumping 9% to $387 million. The life underwriting margin increased by 24% to $482 million, while the health underwriting margin went up by 25% to $108 million. Administrative expenses were $90 million, constituting 7.3% of premium, and the company expects this percentage to remain steady throughout the year. Looking ahead, Globe Life anticipates total premium revenue to grow approximately 5% for the full year 2025, with life premium revenue expected to rise between 3% and 3.5%.

Globe Life Financial Statement Overview

Summary
Globe Life exhibits strong financial performance with impressive revenue growth and solid profitability margins. The balance sheet is stable with a manageable debt level, although the rising debt trend should be monitored. Cash flow generation is robust, but the recent decline in free cash flow growth could pose a challenge if it continues.
Income Statement
75
Positive
Globe Life has demonstrated strong revenue growth with a TTM revenue growth rate of 70.4%, significantly higher than previous periods. The gross profit margin has improved to 60.86% in the TTM, indicating efficient cost management. However, the net profit margin slightly decreased to 18.11% from 18.53% in the previous year, suggesting some pressure on net profitability. Overall, the company shows robust revenue growth and solid profitability margins.
Balance Sheet
70
Positive
The company's debt-to-equity ratio is stable at 0.51, reflecting a balanced approach to leveraging. Return on equity is strong at 20.50%, indicating effective use of equity to generate profits. The equity ratio stands at 18.18%, suggesting a moderate level of equity financing. While the balance sheet shows stability, the increase in total debt over the years could be a potential risk if not managed carefully.
Cash Flow
65
Positive
Operating cash flow remains strong with a coverage ratio of 3.05, indicating good cash generation relative to net income. However, free cash flow growth has been negative in the TTM, which could be a concern if it persists. The free cash flow to net income ratio is healthy at 95.13%, showing efficient cash conversion. Overall, cash flow is solid, but the decline in free cash flow growth warrants attention.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue5.94B5.78B5.45B5.21B5.11B4.74B
Gross Profit2.05B2.47B5.10B4.86B4.79B4.44B
EBITDA1.56B1.45B1.30B1.19B1.36B983.39M
Net Income1.15B1.07B970.75M894.39M1.03B731.77M
Balance Sheet
Total Assets30.53B29.08B28.05B25.54B29.77B29.05B
Cash, Cash Equivalents and Short-Term Investments365.54M250.36M103.16M16.71B21.47B21.42B
Total Debt394.35M2.74B2.12B2.08B2.03B1.92B
Total Liabilities20.63B23.77B23.56B20.64B21.13B20.28B
Stockholders Equity5.69B5.31B4.49B4.90B8.64B8.77B
Cash Flow
Free Cash Flow1.25B1.33B1.43B1.39B1.40B1.43B
Operating Cash Flow1.38B1.40B1.48B1.42B1.44B1.48B
Investing Cash Flow-196.41M-641.52M-926.15M-943.01M-913.37M-1.18B
Financing Cash Flow-1.03B-715.84M-541.49M-492.45M-523.60M-274.06M

Globe Life Technical Analysis

Technical Analysis Sentiment
Negative
Last Price132.24
Price Trends
50DMA
138.13
Negative
100DMA
134.11
Negative
200DMA
128.14
Positive
Market Momentum
MACD
-1.65
Positive
RSI
42.04
Neutral
STOCH
63.58
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GL, the sentiment is Negative. The current price of 132.24 is below the 20-day moving average (MA) of 134.30, below the 50-day MA of 138.13, and above the 200-day MA of 128.14, indicating a neutral trend. The MACD of -1.65 indicates Positive momentum. The RSI at 42.04 is Neutral, neither overbought nor oversold. The STOCH value of 63.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GL.

Globe Life Risk Analysis

Globe Life disclosed 23 risk factors in its most recent earnings report. Globe Life reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Globe Life Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$4.03B12.2210.12%2.86%-4.56%
71
Outperform
$12.85B14.968.35%2.29%1.80%-44.44%
71
Outperform
$10.49B9.5522.28%0.79%3.73%17.47%
68
Neutral
$7.76B3.6721.66%4.37%35.76%636.97%
68
Neutral
$8.11B11.4933.91%1.54%5.63%67.39%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
63
Neutral
$6.26B12.745.50%3.36%24.94%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GL
Globe Life
132.24
24.12
22.31%
LNC
Lincoln National
41.15
7.06
20.71%
PRI
Primerica
252.63
-43.65
-14.73%
UNM
Unum Group
78.15
9.51
13.85%
JXN
Jackson Financial Incorporation
92.88
-16.54
-15.12%
FG
F&G Annuities & Life Inc
30.81
-15.29
-33.17%

Globe Life Corporate Events

Globe Life Inc. Reports Strong Q3 Earnings Amid Challenges
Oct 25, 2025

In the recent earnings call, Globe Life Inc. presented a mixed sentiment with strong growth in net income and insurance operations, alongside positive investment yields and favorable mortality experience. However, the company faced challenges such as flat sales in certain segments, a decline in direct-to-consumer life premiums, low growth in net investment income, and a decrease in excess investment income.

Globe Life Inc. Reports Strong Q3 2025 Earnings
Oct 24, 2025

Globe Life Inc. is a Delaware-based company primarily engaged in offering life and supplemental health insurance products, known for its strong cash flow and stable financial performance in the insurance sector.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 06, 2025